ليست عنوان مقالات لاتين Target setting in the general combined-oriented CCR model using an interactive MOLP method Task mapping on supercomputers with cellular networks Original Research Article

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Target setting in the general combined-oriented CCR model using an interactive MOLP method

2

Target setting in the process of merging and restructuring of decision-making units using multiple objective linear programming

3

Target setting: A generalized concept of centralized resource allocation

4

Target setting: An application to a bank branch network

5

Target set-up for measurements with the use of a Si-ball detector

6

Target set-up for measurements with the use of a Si-ball detector

7

Target shareholdersʹ returns: The effect of diversity in accounting standards and tax treatments in cross-border acquisitions

8

Target Site Insensitivity Detection in Deltamethrin Resistant Culex pipiens Complex in Iran

9

Target site mutation and reduced translocation are present in a glyphosate-resistant Lolium multiflorum Lam. biotype from Spain

10

Target size and optimal life history when individual growth and energy budget are stochastic

11

Target space duality for (0,2) compactifications Original Research Article

12

Target space duality I: general theory Original Research Article

13

Target space duality II: applications Original Research Article

14

Target space duality in orbifolds with continuous and discrete Wilson lines Original Research Article

15

Target space pseudoduality between dual symmetric spaces Original Research Article

16

Target Specificity Analysis of the Abl Kinase using Peptide Microarray Data

17

Target stability and beam-induced background studies at the LUNA underground facility Original Research Article

18

Target strength effect on penetration by shaped charge jets

19

Target Strength Measurement of Myctophid (Benthosema pterotum) in the Oman Sea

20

Target structure and in-beam electron spectra

21

Target Structure-Based Discovery of Small Molecules that Block Human p53 and CREB Binding Protein Association Original Research Article

22

Target studies for the neutrino factory at the Rutherford Appleton laboratory

23

Target studies for the neutrino factory at the Rutherford Appleton laboratory

24

Target syntheses of saturated Keggin polyoxometalate-based extended solids

25

Target synthesis of a new bicapped keggin polyoxometalate derivative: [Co(phen)3]2[SiMoVI 8MoV 4VIV 2O42]$H2O

26

Target system neutronics study for NXGENS

27

Target system neutronics study for NXGENS

28

Target system of IFMIF/EVEDA in Japanese activities

29

Target Systems Overview for the Spallation Neutron Source

30

Target testing procedure for determining chemical kinetics from spectroscopic data with absorption shifts and baseline drift

31

Target thickness optimization design of a spallation neutron source target cooling system

32

Target tracking and boundary node selection algorithms of wireless sensor networks for internet services

33

TARGET TRACKING AND RECEIVER PLACEMENT IN MIMO DVB-T BASED PCL

34

Target Tracking Based on Virtual Grid in Wireless Sensor Networks

35

Target tracking by matching a shape represented by a tree of sigmoid functions

36

Target Tracking in MIMO Radar Systems Using Velocity Vector

37

Target Tracking Techniques for Wireless Sensor Networks

38

Target tracking using Monte Carlo simulation Original Research Article

39

Target tracking with distributed sensors: The focus of attention problem

40

Target tracking with incomplete detection

41

TARGET TRACKING WITH LINE-OF-SIGHT IDENTIFICATION IN SENSOR NETWORKS UNDER UNKNOWN MEASUREMENT NOISES

42

Target Tracking with Unknown Maneuvers Using Adaptive Parameter Estimation in Wireless Sensor Networks

43

Target transform fitting in a voltammetric study of metal complexation Original Research Article

44

Target treatment of female urinary dysfunction

45

Target treatment of female urinary dysfunction

46

Target velocity effects on manual interception kinematics

47

Target Vessel Detection and Coronary Anastomosis Assessment by Intraoperative 12-MHz Ultrasound

48

Target vessel revascularization without cardiopulmonary bypass in elderly high-risk patients

49

Target wave-packet control and its detection using time-resolved photoelectron spectroscopy

50

Target zone credibility and economic fundamentals

51

Target zone dynamics where the fundamental follows a SDE with periodic forcing

52

Target zone models with stochastic realignments: an econometric evaluation

53

Target zones and alternative proposals for G3 policy coordination: An empirical evaluation using GEM

54

Target zones and conditional volatility: The role of realignments

55

Target zones and exchange rates:: An empirical investigation

56

Target zones and small realignments

57

Target zones and small realignments

58

Target zones for exchange rates and policy changes

59

Target zones in theory and history: Credibility, efficiency, and policy autonomy

60

Target zones in theory and history: Credibility, efficiency, and policy autonomy$

61

Target zones, reserve crises, and inverted S-curves

62

Target/Blanket Design for the Accelerator Production of Tritium Plant

63

TARGET: A multi-channel digitizer chip for very-high-energy gamma-ray telescopes

64

Target-acquisition performance in undersampled infrared imagers: static imagery to motion video

65

Target-adaptive polarimetric synthetic aperture radar target discrimination using maximum average correlation height filters

66

Target-aimed versus wishful-thinking in designing efficient GHG reduction strategies for a metropolitan city: Taipei

67

Target-Attainment Rates of Low-Density Lipoprotein Cholesterol Using Lipid-Lowering Drugs One Year After Acute Myocardial Infarction in Sweden

68

Target-based discovery of novel herbicides

69

Target-controlled administration of inhaled anaesthetics

70

TARGET-CONTROLLED INFUSION ANESTHESIA WITH PROPOFOL AND REMIFENTANIL COMPARED WITH MANUALLY CONTROLLED INFUSION ANESTHESIA IN MASTOIDECTOMY SURGERIES

71

Target-controlled infusion of remifentanil with propofol or desflurane under bispectral index guidance: quality of anesthesia and recovery profile

72

Target-Directed Mixture Dynamic Models for Spontaneous Speech Recognition

73

Target-directed visual attention is a prerequisite for action-specific perception

74

Target-driven merging of taxonomies with Atom

75

Targeted (and chemotherapeutic) agents as maintenance treatment in patients with metastatic non-small-cell lung cancer: Current status and future challenges

76

Targeted ablation of gonadotrophs in transgenic mice affects embryonic development of lactotrophs

77

Targeted ablation of SOD1 promotes vascular remodeling induced by periadventitial injury

78

Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer

79

Targeted action on HIV and tuberculosis needed to reach drug users

80

Targeted Activation Tagging of the Arabidopsis NBS-LRR gene, ADR1, Conveys Resistance to Virulent Pathogens.

81

Targeted agents in AML: much more to do

82

Targeted agents in non-small cell lung cancer (NSCLC): Clinical developments and rationale for the combination with thoracic radiotherapy

83

Targeted agents in the third-/fourth-line treatment of patients with advanced (stage III/IV) non-small cell lung cancer (NSCLC)

84

Targeted agents: how can we improve the outcome in biliary tract cancer?

85

Targeted allylation and propargylation of galactose-containing polysaccharides in water

86

Targeted analysis of bioactive phenolic compounds and antioxidant activity of Macedonian red wines

87

Targeted analysis of polyphenol metabolism during development of hop (Humulus lupulus L.) cones following treatment with prohexadione-calcium

88

Targeted analysis with benchtop quadrupole–orbitrap hybrid mass spectrometer: Application to determination of synthetic hormones in animal urine Original Research Article

89

Targeted and intracellular delivery of paclitaxel using multi-functional polymeric micelles

90

Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression

91

Targeted and proximity-dependent promiscuous protein biotinylation by a mutant Escherichia coli biotin protein ligase

92

Targeted and ultrasound-triggered drug delivery using liposomes co-modified with cancer cell-targeting aptamers and a thermosensitive polymer

93

Targeted and ultrasound-triggered drug delivery using liposomes co-modified with cancer cell-targeting aptamers and a thermosensitive polymer

94

Targeted annotation of immunoglobulin light chain (IgL) genes in zebrafish from BAC clones reveals kappa-like recombining/deleting elements within IgL constant regions

95

Targeted Anticancer Therapies: Mouse Models Help Uncover the Mechanisms of Tumor Escape

96

Targeted Anticancer Therapies: Mouse Models Help Uncover the Mechanisms of Tumor Escape

97

Targeted Antipeptide Antibodies to Cytochrome P450 2C18 Based on Epitope Mapping of an Inhibitory Monoclonal Antibody to P450 2C51

98

Targeted binding of a platinum(II)–methionine complex to the disulfide linkage of a nonapeptide oxytocin

99

Targeted binding of PLA microparticles with lipid-PEG-tethered ligands

100

Targeted biopharmaceuticals for cancer treatment

101

Targeted bone remodeling involves BMU steering as well as activation

102

Targeted brain hypothermia induced by an interstitial cooling device in the rat neck: Experimental study and model validation

103

Targeted breast cancer screening in women younger than 40: results from a statewide program

104

Targeted Cancer Diagnostic and Therapeutic Agents: Delivery by Carriers or Conjugation

105

Targeted Cancer Therapy: A Hopeful Cure for Future

106

Targeted cardiac expression of soluble Fas prevents the development of heart failure in mice with cardiac-specific expression of MCP-1

107

Targeted cellular adhesion at biomaterial interfaces

108

Targeted Chemical-Genetic Regulation of Protein Stability In Vivo Original Research Article

109

Targeted chemotherapy in mice with peritoneally disseminated gastric cancer using monoclonal antibody–drug conjugate

110

Targeted chemotherapy with cytotoxic bombesin analogue AN-215 can overcome chemoresistance in experimental renal cell carcinomas: Keller G, Schally AV, Nagy A, Halmos G, Baker B, Engel JB, Endocrine, Polypeptide, and Cancer Institute, Veterans Affairs Med

111

Targeted Co-Delivery of Docetaxel and cMET siRNA for Treatment of Mucin1 Overexpressing Breast Cancer Cells

112

Targeted computational probabilistic corroboration of experimental knee wear simulator: The importance of accounting for variability

113

Targeted Correction of the Point Mutations of β-Thalassemia and Targeted Mutagenesis of the Nucleotide Associated with HPFH by RNA/DNA Oligonucleotides: Potential for β-Thalassemia Gene Therapy

114

Targeted cytotoxic analog of luteinizing hormone–releasing hormone AN-207 inhibits growth of OV-1063 human epithelial ovarian cancers in nude mice, ,

115

Targeted cytotoxic somatostatin analog AN-162 inhibits growth of human colon carcinomas and increases sensitivity of doxorubicin resistant murine leukemia cells

116

Targeted damage effects of high intensity focused ultrasound (HIFU) on liver tissues of Guizhou province miniswine

117

Targeted damage effects of high intensity focused ultrasound (HIFU) on liver tissues of Guizhou province miniswine

118

Targeted Deletion of AIF Decreases Mitochondrial Oxidative Phosphorylation and Protects from Obesity and Diabetes

119

Targeted deletion of caspase-1 reduces early mortality and left ventricular dilatation following myocardial infarction

120

Targeted Deletion of Los1 Homologue Affects the Production of a Recombinant Model Protein in Pichia pastoris

121

Targeted Deletion of the A3Adenosine Receptor Confers Resistance to Myocardial Ischemic Injury and does not Prevent Early Preconditioning

122

Targeted Deletion of the Calcineurin Inhibitor DSCR1 Suppresses Tumor Growth

123

Targeted Deletion Reveals Essential and Overlapping Functions of the miR-17∼92 Family of miRNA Clusters

124

Targeted Delivery of 5-fluorouracil with Monoclonal Antibody Modified Bovine Serum Albumin Nanoparticles

125

Targeted Delivery of Anti-CTLA-4 Antibody Downregulates T Cell Function in Vitro and in Vivo

126

Targeted delivery of doxorubicin and therapeutic FOXM1 aptamer to tumor cells using gold nanoparticles modified with AS1411 and ATP aptamers

127

Targeted delivery of doxorubicin into tumor cells via MMP-sensitive PEG hydrogel-coated magnetic iron oxide nanoparticles (MIONPs)

128

Targeted delivery of EV peptide to tumor cell cytoplasm using lipid coated calcium carbonate nanoparticles

129

Targeted delivery of galbanic acid to colon cancer cells by PLGA nanoparticles incorporated into human mesenchymal stem cells

130

Targeted delivery of heparin and LMWH using a fibrin antibody prevents restenosis

131

Targeted delivery of low molecular drugs using chitosan and its derivatives

132

Targeted delivery of mannan-coated superparamagnetic iron oxide nanoparticles to antigen-presenting cells for magnetic resonance-based diagnosis of metastatic lymph nodes in vivo

133

Targeted delivery of nanoparticles for the treatment of lung diseases

134

Targeted delivery of paclitaxel using folate-conjugated heparin-poly(β-benzyl-l-aspartate) self-assembled nanoparticles

135

Targeted delivery of paclitaxel using folate-decorated poly(lactide)–vitamin E TPGS nanoparticles

136

Targeted Delivery of Pennyroyal via Methotrexate Functionalized PEGylated Nanostructured Lipid Carriers into Breast Cancer Cells; A Multiple Pathways Apoptosis Activator

137

Targeted delivery of the ErbB2/HER2 tumor antigen to professional APCs results in effective antitumor immunity: Rohrbach F, Weth R, Kursar M, Sloots A, Mittrucker HW, Wels WS, Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Frankfurt am Main, G

138

Targeted Delivery of Therapeutic Agents by Smart Nanocarrier for Treatment of Parkinson’s Disease: A Novel Brain Targeting Approach

139

Targeted delivery of therapeutics to bone and connective tissues

140

Targeted delivery of thrombolytic enzymes

141

Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment

142

Targeted delivery system for juxtacrine signaling growth factor based on rhBMP-2-mediated carrier-protein conjugation

143

Targeted delivery to the nucleus

144

Targeted delivery using inorganic nanosystem

145

Targeted deposition of a conducting polymer based on bipolar electrochemistry

146

Targeted deposition of a conducting polymer based on bipolar electrochemistry

147

Targeted deposition of Au aerosol nanoparticles on vertical nanowires for the creation of nanotrees

148

Targeted destruction of murine macrophage cells with bioconjugated gold nanorods

149

Targeted detection of the cancer cells using the anti-CD24 bio modified PEGylated gold nanoparticles: the application of CD24 as a vital cancer biomarker

150

Targeted disease prophylaxis in European fish farming (TargetFish)

151

Targeted Disruption of Heparan Sulfate Interaction with Hepatocyte and Vascular Endothelial Growth Factors Blocks Normal and Oncogenic Signaling

152

Targeted disruption of PPARγ in bone marrow stromal cells reveals its role in aging-induced bone loss

153

Targeted Disruption of the CCR5 Gene in Human Hematopoietic Stem Cells Stimulated by Peptide Nucleic Acids Original Research Article

154

Targeted disruption of the galectin-3 gene results in decreased susceptibility to multiple low dose streptozotocin-induced diabetes in mice

155

Targeted disruption of the glutaredoxin 1 gene does not sensitize adult mice to tissue injury induced by ischemia/reperfusion and hyperoxia

156

Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis

157

Targeted disruption of β1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction

158

Targeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cells

159

Targeted drug conjugates: principles and progress

160

Targeted drug delivery by thermally responsive polymers

161

Targeted drug delivery for musculoskeletal diseases

162

Targeted Drug Delivery in Lipid-like Nanocages and Extracellular Vesicles

163

Targeted drug delivery using silica xerogel systems to treat diseases due to intracellular pathogens

164

Targeted drug delivery via the folate receptor

165

Targeted drug delivery via the folate receptor

166

Targeted drug delivery with dendrimers: Comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex

167

Targeted drugs for metastatic renal cell carcinoma

168

Targeted drugs take centre stage at US cancer meeting

169

Targeted eicosanoids lipidomics of exhaled breath condensate in healthy subjects

170

Targeted energy transfer between a Rotor and a Morse oscillator: A model for selective chemical dissociation

171

Targeted energy transfer by Fermi resonance

172

Targeted energy transfer in systems with non-polynomial nonlinearity

173

Targeted enhancement of oleoylethanolamide mobilization in proximal small intestine induces across-meal satiety in rats

174

Targeted Enrollment of Medical Students for Rural China: Prospects and Challenges

175

Targeted epidermal growth factor receptor therapy in malignant pleural mesothelioma: Where do we stand?

176

Targeted ethnography as a critical step to inform cultural adaptations of HIV prevention interventions for adults with severe mental illness

177

Targeted Expression of BikDD Eradicates Pancreatic Tumors in Noninvasive Imaging Models

178

Targeted expression of csCSF-1 in op/op mice ameliorates tooth defects

179

Targeted Fluoromagnetic Nanoparticles for Imaging of Breast Cancer MCF-7 Cells

180

Targeted food supplementation through National Nutrition Program and pregnancy weight gain status in selected upazilas

181

Targeted Fully Homomorphic Encryption Based on a Double Decryption Algorithm for Polynomials

182

Targeted gene analysis in Ulmus americana and U. pumila tissues

183

Targeted gene delivery in the cricket brain, using in vivo electroporation

184

Targeted gene delivery to the brain using CDX-modified chitosan nanoparticles

185

Targeted Gene Disruption in the Development of Mouse Models to Elucidate the Role of Receptor Guanylyl Cyclase Signaling Pathways in Physiological Function

186

Targeted Gene Disruption of theCaenorhabditis elegansl-Isoaspartyl Protein Repair Methyltransferase Impairs Survival of Dauer Stage Nematodes

187

Targeted Gene Expression Profiling in the Rainbow Trout (Oncorhynchus mykiss) Ovary During Maturational Competence Acquisition and Oocyte Maturation

188

Targeted Gene Expression Using the GAL4/UAS System in the Silkworm Bombyx mori

189

Targeted Gene Therapy of Cancer: Second Amendment toward Holistic Therapy

190

Targeted gene therapy: frontiers in the development of ‘smart drugs’

191

Targeted gene transduction of mammalian cells expressing the HER2/neu receptor by filamentous phage

192

Targeted gene-delivery strategies for angiostatic cancer treatment

193

Targeted glycoproteomics: Serial lectin affinity chromatography in the selection of O-glycosylation sites on proteins from the human blood proteome

194

Targeted GOES Satellite Observations to Improve Hurricane Track Forecast: A Case Study of Hurricane Floyd

195

Targeted heat transfer augmentation in circular tubes using a corona jet

196

Targeted high-efficiency, homogeneous myocardial gene transfer

197

Targeted human cerebrospinal fluid proteomics for the validation of multiple Alzheimerʹs disease biomarker candidates

198

Targeted hyperthermia using metal nanoparticles

199

Targeted imaging

200

Targeted immunosuppression: No longer naïve

201

Targeted improvement of Steinernema carpocapsae for control of the pecan weevil, Curculio caryae (Horn) (Coleoptera: Curculionidae) through hybridization and bacterial transfer

202

Targeted in vitro photodynamic therapy via aptamer-labeled, porphyrin-loaded virus capsids

203

Targeted Inactivation of Fh1 Causes Proliferative Renal Cyst Development and Activation of the Hypoxia Pathway

204

Targeted Inactivation of Mdm2 RING Finger E3 Ubiquitin Ligase Activity in the Mouse Reveals Mechanistic Insights into p53 Regulation

205

Targeted inactivation of the murine cardiac myosin-binding protein C gene leads to hypertrophic cardiomyopathy

206

Targeted inactivation of vitamin D hydroxylases in mice

207

Targeted induction of apoptosis for cancer therapy: current progress and prospects

208

Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: A potential mechanism of tumor-immune privilege

209

Targeted inhibition of hedgehog signaling by cyclopamine prodrugs for advanced prostate cancer Original Research Article

210

Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: Potential role in prevention and therapy of cancer

211

Targeted Inhibition of β-Adrenergic Receptor Kinase-1–Associated Phosphoinositide-3 Kinase Activity Preserves β-Adrenergic Receptor Signaling and Prolongs Survival in Heart Failure Induced by Calsequestrin Overexpression Original Research Article

212

Targeted integration of adenovirus vectors in hematopoietic stem cells

213

Targeted intervention for multiple language disorders: a case study

214

Targeted intervention for the ultra poor in rural Bangladesh: Does it make any difference in their health-seeking behaviour?

215

Targeted intracellular catalase delivery protects neonatal rat myocytes from hypoxia-reoxygenation and ischemia-reperfusion injury

216

Targeted Intracellular Heat Transfer in Cancer Therapy: Assessment of Asparagine-laminated Gold Nanoparticles in Cell Model of T cell Leukemia

217

Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomics

218

Targeted Iron Oxide Particles for In Vivo Magnetic Resonance Detection of Atherosclerotic Lesions With Antibodies Directed to Oxidation-Specific Epitopes

219

Targeted knockdown of canine KIT (stem cell factor receptor) using RNA interference

220

Targeted knockdown of canine KIT (stem cell factor receptor) using RNA interference

221

Targeted Left Ventricular Lead Placement to Guide Cardiac Resynchronization Therapy: The TARGET Study: A Randomized, Controlled Trial

222

Targeted lipidomics approach for endogenous N-acyl amino acids in rat brain tissue

223

Targeted Lung Cancer Treatments and Eye Metastasis

224

Targeted manipulation of apoptotic pathways by using High Intensity Focused Ultrasound in cancer treatment

225

Targeted Marketing in Herbal Medicine; Application for Grounded Theory and K- Mean Algorithm

226

Targeted mass spectral ratio analysis: A new tool for gas chromatography—mass spectrometry

227

Targeted mass treatment for syphilis with oral azithromycin

228

Targeted material design of flyash filled composites for friction braking application by non-linear regression optimization technique

229

Targeted metabolic profiling of phenolics in urine and plasma after regular consumption of cocoa by liquid chromatography–tandem mass spectrometry

230

Targeted metabolite analysis of Catharanthus roseus and its biological potential

231

Targeted metabolomic analysis of plasma samples for the diagnosis of inherited metabolic disorders

232

Targeted Methylation and Gene Silencing of VEGF-A in Human Cells by Using a Designed Dnmt3a–Dnmt3L Single-Chain Fusion Protein with Increased DNA Methylation Activity

233

Targeted microbubbles for ultrasound mediated gene transfection and apoptosis induction in ovarian cancer cells

234

Targeted microbubbles for ultrasound mediated gene transfection and apoptosis induction in ovarian cancer cells

235

Targeted mining of drought stress-responsive genes from EST resources in Cleistogenes songorica

236

Targeted Modification of Homogalacturonan by Transgenic Expression of a Fungal Polygalacturonase Alters Plant Growth

237

Targeted Molecular Imaging Agents for Cellular-Scale Bimodal Imaging

238

Targeted multidimensional gas chromatography for the quantitative analysis of suspected allergens in fragrance products

239

Targeted Multidimensional Gas Chromatography Using Microswitching and Cryogenic Modulation

240

Targeted multimodal imaging modalities

241

Targeted mutagenesis of the Clostridium acetobutylicum acetone–butanol–ethanol fermentation pathway

242

Targeted mutation breeding of horticultural plants

243

Targeted MYCN expression affects cytotoxic potential of chemotherapeutic drugs in neuroblastoma cells

244

Targeted Myocardial Microinjections of a Biocomposite Material Reduces Infarct Expansion in Pigs

245

Targeted naltrexone treatment of early problem drinkers

246

Targeted Nanoblobs Spot Treat Cancer and Heart Disease

247

Targeted nanocarriers for imaging and therapy of vascular inflammation

248

Targeted Nanoparticle Therapy with Betaine-Conjugated Gold Nanoparticles Reduces Inflammation and Makes Immunomodulation in Heatstroke in Mice

249

Targeted nanoparticles for cancer therapy

250

Targeted nanoparticles for simultaneous delivery of chemotherapeutic and hyperthermia agents – An in vitro study

251

Targeted nanoparticles with novel non-peptidic ligands for oral delivery

252

Targeted nanotechnology for cancer imaging

253

Targeted Next Generation Sequencing (NGS) to Diagnose Hereditary Hemolytic Anemias

254

Targeted Next Generation Sequencing Reveals a Novel Intragenic Deletion of the TPO Gene in a Family with Intellectual Disability

255

Targeted Next-Generation Sequencing Identifies Pathogenic Variants in Familial Congenital Heart Disease

256

Targeted NF-κB inhibition of asthmatic serum-mediated human monocyte-derived dendritic cell differentiation in a transendothelial trafficking model

257

Targeted nNOS gene transfer into the cardiac vagus rapidly increases parasympathetic function in the pig

258

Targeted nucleic acid delivery into tumors: new avenues for cancer therapy

259

Targeted Nucleotide Exchange in Saccharomyces cerevisiae Directed by Short Oligonucleotides Containing Locked Nucleic Acids Original Research Article

260

Targeted Nucleotide Repair of cyc1 Mutations in Saccharomyces cerevisiae Directed by Modified SingleStranded DNA Oligonucleotides

261

Targeted nutrition in the critically ill: a therapeutic modality for the new millennium?

262

Targeted Nutritional and Behavioral Feeding Intervention fora Child with Autism Spectrum Disorder

263

Targeted Optical Imaging Agents in Cancer: Focus on Clinical Applications

264

Targeted Overactivity of β Cell KATP Channels Induces Profound Neonatal Diabetes

265

Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy

266

Targeted Overexpression of Phospholamban to Mouse Atrium Depresses Ca2+Transport and Contractility

267

Targeted peptides for the quantitative evaluation of casein plasminolysis in drinking milk

268

Targeted pharmacological reversal of electrical remodeling after cardioversion—Rationale and design of the Flecainide Short-Long (Flec-SL) trial

269

Targeted phase II metabolites profiling as new screening strategy to investigate natural steroid abuse in animal breeding Original Research Article

270

Targeted photodynamic therapy via receptor mediated delivery systems

271

Targeted Photothermal Therapy of Melanoma in C57BL/6 Mice using Fe3O4@Au Core-shell Nanoparticles and Near-infrared Laser

272

Targeted prenatal herpes simplex virus testing: Can we identify women at risk of transmission to the neonate?

273

Targeted processor architectures for high-performance controller implementation

274

Targeted profiling of polar intracellular metabolites using ion-pair-high performance liquid chromatography and -ultra high performance liquid chromatography coupled to tandem mass spectrometry: Applications to serum, urine and tissue extracts

275

Targeted programs v the basic income guarantee: an examination of the efficiency costs of different forms of redistribution

276

Targeted Protein Functionalization Using His-Tags

277

Targeted proteomics for metabolic pathway optimization: Application to terpene production

278

Targeted quantitative analysis of eicosanoid lipids in biological samples using liquid chromatography–tandem mass spectrometry

279

Targeted quantitative analysis of fatty acids in atherosclerotic plaques by high sensitivity liquid chromatography/tandem mass spectrometry

280

Targeted quantitative analysis of superoxide dismutase 1 in cisplatin-sensitive and cisplatin-resistant human ovarian cancer cells

281

Targeted radiofrequency field mapping using 3D reduced field-of-view-catalyzed double-angle method

282

Targeted radio-nuclide therapy of skeletal metastases

283

Targeted reduction of complex models with time scale hierarchy – a case study

284

Targeted reinnervation for enhanced prosthetic arm function in a woman with a proximal amputation: a case study

285

Targeted Remodeling of Human β-Globin Promoter Chromatin Structure Produces Increased Expression and Decreased Silencing

286

Targeted removal of bioavailable metal as a detoxification strategy for carbon nanotubes Original Research Article

287

Targeted renal therapies through microbubbles and ultrasound

288

Targeted RNAi of the Mitogen-activated Protein Kinase Pathway Genes in Acute Myeloid Leukemia Cells

289

Targeted Sampling Protocol as Prelude to Bacterial Source Tracking with Enterococcus faecalis

290

Targeted saving by renters for housing purchase in Japan

291

Targeted Screening for Predominant CYP1B1 Mutations in Primary Congenital Glaucoma

292

Targeted Screening of Membrane Proteins of Haemophilus Ducreyi with the Aim of Drug Targets Identification

293

Targeted separation of antibacterial peptide from protein hydrolysate of anchovy cooking wastewater by equilibrium dialysis

294

Targeted Shapiro filter in an ocean model

295

Targeted silencing of TRPM7 ion channel induces replicative senescence and produces enhanced cytotoxicity with gemcitabine in pancreatic adenocarcinoma

296

Targeted Single-Cell Microchemical Analysis: MS-Based Peptidomics of Individual Paraformaldehyde-Fixed and Immunolabeled Neurons Original Research Article

297

Targeted Solid Lipid Nanoparticles Formulation for Colon Cancer Treatment and Cytotoxicity Assessment Using HT29 Cell Line

298

Targeted sonocatalytic cancer cell injury using avidin-conjugated titanium dioxide nanoparticles

299

Targeted sonocatalytic cancer cell injury using avidin-conjugated titanium dioxide nanoparticles

300

Targeted sonodynamic therapy using protein-modified TiO2 nanoparticles

301

Targeted sonodynamic therapy using protein-modified TiO2 nanoparticles

302

Targeted spray technology to reduce pesticide in runoff from dormant orchards

303

Targeted stable-isotope dilution GC–MS/MS analysis of the endocannabinoid anandamide and other fatty acid ethanol amides in human plasma

304

Targeted Stimulation of Meiotic Recombination

305

Targeted study to evaluate the cardiovascular risk factor status among patients and efficacy of statins in attaining goal lipid levels in a regional hospital in Sultanate of Oman

306

Targeted synthesis of 2,3-disubstituted 2-phospholenes using catalytic cycloalumination of acetylenes

307

Targeted therapeutic approaches for hormone-refractory prostate cancer

308

Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials

309

Targeted therapies for advanced non-small-cell lung cancer: Current status and future implications

310

Targeted Therapies for Hepatitis C Reach the Clinic

311

Targeted therapies for kidney cancer in urologic practice

312

Targeted therapies for squamous cell carcinoma of the head and neck: Current knowledge and future directions

313

Targeted therapies for the treatment of cancer

314

Targeted therapies in bladder cancer—an update

315

Targeted therapies in melanoma

316

Targeted therapies in non-muscle-invasive bladder cancer according to the signaling pathways

317

Targeted therapies of cancer: Angiogenesis inhibition seems not enough

318

Targeted therapy against chemoresistant colorectal cancers: Inhibition of p38α modulates the effect of cisplatin in vitro and in vivo through the tumor suppressor FoxO3A

319

Targeted therapy comes of age in scleroderma

320

Targeted therapy for colorectal cancer: mapping the way

321

Targeted therapy for soft tissue sarcomas in adolescents and young adults

322

Targeted therapy for systemic sclerosis

323

Targeted therapy for uveal melanoma

324

Targeted therapy in advanced non-small cell lung cancer (NSCLC): Where do we stand?

325

Targeted therapy in metastatic colorectal cancer – An example of personalised medicine in action

326

Targeted therapy in metastatic renal carcinoma

327

Targeted therapy of multiple myeloma based upon tumor-microenvironmental interactions

328

Targeted thiolation of graphene oxide and its utilization as precursor for graphene/silver nanoparticles composites Original Research Article

329

Targeted three-dimensional liquid chromatography: A versatile tool for quantitative trace analysis in complex matrices

330

Targeted toxins in pain

331

Targeted transfection of the IL-3 gene into primary human hematopoietic progenitor cells through the c-kit receptor

332

Targeted transfers and the fiscal response to the great recession

333

Targeted treatment for incontinence beckons

334

Targeted treatment of catastrophizing for the management of chronic pain Original Research Article

335

Targeted treatments for symptom domains in child and adolescent autism

336

Targetedtransfersandthefiscalresponsetothegreatrecession

337

Target–flanker discriminability affects conflict size but not sustained suppression

338

Target-guided isolation and purification of antioxidants from Selaginella sinensis by offline coupling of DPPH-HPLC and HSCCC experiments

339

Target-guided separation of Bougainvillea glabra betacyanins by direct coupling of preparative ion-pair high-speed countercurrent chromatography and electrospray ionization mass-spectrometry

340

Target-induced anergy of natural killer cytotoxic function is restricted to the NK—target conjugate subset

341

Target-induced aptamer release strategy based on electrochemical detection of staphylococcal enterotoxin B using GNPs-ZrO2-Chits film

342

Target-induced conformational adaptation of calmodulin revealed by the crystal structure of a complex with nematode Ca2+/calmodulin-dependent kinase kinase peptide

343

Target-induced selection of ligands from a dynamic combinatorial library of mono- and bi-conjugated oligonucleotides

344

Targeting [AuCl2(CN)2]− units as halophilic building blocks in coordination polymers

345

Targeting a cornerstone of radiation resistance: Cancer stem cell

346

Targeting a Dual Detector of Skin and CO2 to Modify Mosquito Host Seeking

347

Targeting a marker of the tumour neovasculature using a novel anti-human CD105-immunotoxin containing the non-toxic type 2 ribosome-inactivating protein nigrin b

348

Targeting a polyketide synthase gene for Aspergillus carbonarius quantification and ochratoxin A assessment in grapes using real-time PCR

349

Targeting a Prokaryotic Protein in a Eukaryotic Pathogen: Identification of Lead Compounds against Cryptosporidiosis

350

Targeting a Prokaryotic Protein in a Eukaryotic Pathogen: Identification of Lead Compounds against Cryptosporidiosis Original Research Article

351

Targeting a ruthenium complex to the nucleus with short peptides Original Research Article

352

Targeting a Uniquely Nonspecific Prenyl Synthase with Bisphosphonates to Combat Cryptosporidiosis Original Research Article

353

Targeting Acceptance, Mindfulness, and Values-Based Action in Chronic Pain: Findings of Two Preliminary Trials of an Outpatient Group-Based Intervention Original Research Article

354

Targeting ACE and ECE with dual acting inhibitors

355

Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer

356

Targeting ADAMS and ERBBs in lung cancer

357

Targeting adolescent risk-taking behaviors: the contributions of egocentrism and sensation-seeking

358

Targeting Advanced Glycation End Products in Cardiac Surgery: The Unexplored Alternative

359

Targeting agricultural research based on potential impacts on poverty reduction: Strategic program priorities by agro-ecological zone in Nigeria

360

Targeting agricultural research to benefit poor farmers: Relating poverty mapping to maize environments in Mexico

361

Targeting agri-environmental policy : An analysis relating to the use of Geographical Information Systems

362

Targeting airline advertising copy

363

Targeting ALT: The role of alternative lengthening of telomeres in pathogenesis and prevention of cancer

364

Targeting Altered Mitochondrial Biogenesis in the Brain of Diabetic Rats: Potential Effect of Pioglitazone and Exendin-4

365

Targeting Alzheimer’s disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238 Original Research Article

366

Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells

367

Targeting an Old Mechanism in a New Disease—Protection of Glutamatergic Dysfunction in Depression

368

Targeting and anti-tumor efficacy of liposomal 5′-O-dipalmitoylphosphatidyl 2′-C-cyano-2′-deoxy-1-β-d-arabino-pentofuranosylcytosine in mice lung bearing B16BL6 melanoma

369

Targeting and impacts of AgI cloud seeding based on rain chemical composition and cloud top phase characterization

370

Targeting and implementing payments for ecosystem services: Opportunities for bundling biodiversity conservation with carbon and water services in Madagascar

371

Targeting and Inhibiting Plasmodium berghei Growth in Balb/c Mice Using Kojic Acid-Solid Lipid Nanoparticles and Kojic Acid-Nanostructured Lipid Carriers

372

Targeting and scheduling problem for field artillery

373

Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer

374

Targeting Aneuploidy for Cancer Therapy

375

Targeting angiogenesis in pancreatic cancer

376

Targeting Apo2L/TRAIL receptors by soluble Apo2L/TRAIL

377

Targeting apoptosis pathways by Celecoxib in cancer

378

Targeting apoptosis pathways by natural compounds in cancer: Marine compounds as lead structures and chemical tools for cancer therapy

379

Targeting apoptosis pathways in cancer by Chinese medicine

380

Targeting apoptosis pathways in cancer stem cells

381

Targeting apoptosis pathways in childhood malignancies

382

Targeting apoptosis pathways in glioblastoma

383

Targeting apoptosis pathways in lung cancer

384

Targeting apoptosis pathways in pancreatic cancer

385

Targeting apoptosis proteins in hematological malignancies

386

Targeting Apoptosis via Chemical Design: Inhibition of Bid-Induced Cell Death by Small Organic Molecules Original Research Article

387

Targeting apoptotic and autophagic pathways for cancer therapeutics

388

Targeting ASIC1a Reduces Innate Fear and Alters Neuronal Activity in the Fear Circuit

389

Targeting ATR in DNA damage response and cancer therapeutics

390

Targeting autoimmune diseases through nutraceuticals

391

Targeting autophagy for breast cancer prevention and therapy: From classical methods to phytochemical agents

392

Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells

393

Targeting Bacterial Virulence: Inhibitors of Type III Secretion in Yersinia Original Research Article

394

Targeting Bcl-2 family proteins in adult T-cell leukemia/lymphoma: In vitro and in vivo effects of the novel Bcl-2 family inhibitor ABT-737

395

Targeting biological control across diverse landscapes: the release, establishment, and early success of two insects on mesquite (Prosopis spp.) insects in Australian rangelands

396

Targeting Brain Regions and Symptoms: Neuronal Single-Unit Recordings and Deep Brain Stimulation in Obsessive-Compulsive Disorder

397

Targeting Breast and Cervical Cancer Screening to Elderly Poor Black Women: Who Will Participate?

398

Targeting Breast and Prostate Cancers Through Their Hormone Receptors

399

Targeting Breast Cancer With Bio-inspired Virus Nanoparticles

400

Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis

401

Targeting cancer cells by exploiting their resistance

402

Targeting cancer cells through iron(III) complexes of di(picolyl)amine modified silica core–shell nanospheres

403

Targeting Cancer Cells with Dendrimers

404

Targeting cancer cells with nucleic acid aptamers

405

Targeting cancer cells with transferrin conjugates containing the non-toxic type 2 ribosome-inactivating proteins nigrin b or ebulin l

406

Targeting cancer stem cells by curcumin and clinical applications

407

Targeting Cancer Stem Cells, The Major Leap Toward a Cure

408

Targeting cancer using cholesterol conjugates

409

Targeting Capacity and Conservation of PreP Homologues Localization in Mitochondria of Different Species

410

Targeting cathepsin S induces tumor cell autophagy via the EGFR–ERK signaling pathway

411

Targeting cell regulation promotes pathogen survival in macrophages

412

Targeting c-FLIP in cancer

413

Targeting Cholesteryl Ester Transfer Protein for the Prevention and Management of Cardiovascular Disease Review Article

414

Targeting cogeneration and waste utilization through process integration

415

Targeting Colorectal Cancer Cell Lines Using Nanobodies; AgSK1as a Potential Target

416

Targeting commercial sex-workers in Goa, India: time for a strategic rethink?

417

Targeting conservation agriculture in the context of livelihoods and landscapes

418

Targeting conservation efforts in the presence of threshold effects and ecosystem linkages

419

Targeting Conservation Investments in Heterogeneous Landscapes: A DistanceFunction Approach and Application to Watershed Management

420

Targeting conservation payments to achieve multiple outcomes Original Research Article

421

Targeting conservation–development initiatives in tropical forests: insights from analyses of rain forest use and economic reliance among Amazonian peasants

422

Targeting Copper Dyshomeostasis as a Pathophysiological Basis of Childhood Obesity: Latest Facts

423

Targeting C-type lectin receptors with multivalent carbohydrate ligands

424

Targeting cultural changes supportive of the healthiest lifestyle patterns. A biosocial evidence-base for prevention of obesity

425

Targeting customers via discovery knowledge for the insurance industry

426

TARGETING CUSTOMERS: A FUZZY CLASSIFICATION APPROACH

427

Targeting cyclooxygenase-2 in human neoplasia: Rationale and promise

428

Targeting cytochrome P450 enzymes: A new approach in anti-cancer drug development Review Article

429

Targeting cytokines in asthma therapy: round one

430

Targeting deeper the human serum fucome by a liquid-phase multicolumn platform in combination with combinatorial peptide ligand libraries

431

Targeting delivery of paclitaxel into tumor cells via somatostatin receptor endocytosis Original Research Article

432

Targeting dendritic cells with biomaterials: developing the next generation of vaccines

433

Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations

434

Targeting development assistance to meet WSSD goals for large marine ecosystems and small island developing states

435

Targeting disadvantage in agriculture

436

Targeting dispositions for drug-involved offenders: A field trial of the Risk and Needs Triage (RANT)™

437

Targeting DNA abasic site by myricetin: Sequence-dependent ESIPT emission

438

Targeting DNA Bulged Microenvironments with Synthetic Agents: Lessons from a Natural Product Original Research Article

439

Targeting DNA methylation in cancer

440

Targeting DNA repair in breast cancer: A clinical and translational update

441

Targeting DNA repair pathways: A novel approach to reduce cancer therapeutic resistance

442

Targeting DNA topoisomerase II with podophyllotoxin aza-analogue

443

Targeting duplex DNA with DNA-PNA chimeras? Physico-chemical characterization of a triplex DNA-PNA/DNA/DNA

444

Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence

445

Targeting education: The politics of performance and the prospects of ‘Education For All’

446

Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer

447

Targeting efflux pumps—In vitro investigations with acridone derivatives and identification of a lead molecule for MDR modulation Original Research Article

448

Targeting energy metabolism in Huntingtonʹs disease

449

Targeting enforcement to improve compliance with environmental regulations

450

Targeting enzymes to the right compartment: Metabolic engineering for itaconic acid production by Aspergillus niger

451

Targeting epidermal growth factor receptor—are we missing the mark?

452

Targeting Epigenetic Misregulation in Synovial Sarcoma

453

Targeting ER stress induced apoptosis and inflammation in cancer

454

Targeting ergonomics interventions—learning from health promotion

455

Targeting excessive free radicals with peels and juices of citrus fruits: Grapefruit, lemon, lime and orange

456

Targeting farnesoid X receptor for liver and metabolic disorders

457

Targeting fibroblast-like synovial cells at sites of inflammation with peptide targeted liposomes results in inhibition of experimental arthritis

458

Targeting for carbon sequestration retrofit planning in the power generation sector for multi-period problems

459

Targeting for cogeneration potential through total site integration

460

Targeting for pollution prevention through process simulation

461

Targeting FOXO Kills Two Birds with One Stone Review Article

462

Targeting fungi: A challenge

463

Targeting G protein coupled receptor-related pathways as emerging molecular therapies

464

Targeting GABARAPL1/HIF-2a axis to induce tumor cell apoptosis in nasopharyngeal carcinoma

465

Targeting Gastric Cancer Stem Cells through Developmental Pathways: Hypothesis

466

Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine–bombesin conjugate

467

Targeting GATA-1 to binding sites in nuclear chromatin

468

Targeting GD2 ganglioside and aurora A kinase as a dual strategy leading to cell death in cultures of human neuroblastoma cells

469

Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin-1 promoter

470

Targeting gene expression using HSV vectors

471

Targeting gene therapy for hepatocarcinoma cells with the E. coli purine nucleoside phosphorylase suicide gene system directed by a chimeric α-fetoprotein promoter

472

Targeting genetic resource conservation in widespread species: a case study of Cedrela odorata L.

473

Targeting Glycosylation Pathways and the Cell Cycle: Sugar-Dependent Activity of Butyrate-Carbohydrate Cancer Prodrugs Original Research Article

474

Targeting gut microbiota in hepatocellular carcinoma: probiotics as a novel therapy

475

Targeting heat shock factor 1 with a triazole nucleoside analog to elicit potent anticancer activity on drug-resistant pancreatic cancer

476

Targeting heat shock proteins in cancer

477

Targeting HER-2/neu-overexpressing breast cancer cells by an antisense iron responsive element-directed gene expression

478

Targeting high-performance liquid chromatography–high-resolution mass spectrometry–solid-phase extraction–nuclear magnetic resonance analysis with high-resolution radical scavenging profiles—Bioactive secondary metabolites from the endophytic fungus Penic

479

Targeting HIV: Beyond Protease and Reverse Transcriptase Inhibitors

480

Targeting HPC with the help of nanoparticles: An overview

481

Targeting HSP90 to Halt Neurodegeneration

482

Targeting Human Telomerase Reverse Transcriptase by a Simple siRNA Expression Cassette in HepG2 Cells

483

Targeting IL-17 in psoriasis: From cutaneous immunobiology to clinical application

484

Targeting IL-2 to the endoplasmic reticulum confines autocrine growth stimulation to NK-92 cells

485

Targeting Immunosupportive Cancer Therapies: Accentuate the Positive, Eliminate the Negative

486

Targeting improved DMFC performance

487

Targeting in the presence of noise

488

Targeting inflation by forecast feedback rules in small open economies

489

Targeting inflation over the short, medium and long term

490

Targeting inflation: Comparative control exercises on models of the UK economy

491

Targeting iNKT cells for the treatment of sickle cell disease

492

Targeting innovation and implications for capability development

493

Targeting integrins: Insights into structure and activity of cyclic RGD pentapeptide mimics containing azabicycloalkane amino acids Original Research Article

494

Targeting intelligence gathering in a dynamic competitive environment

495

Targeting interferon regulatory factors to inhibit activation of the type I IFN response: Implications for treatment of autoimmune disorders

496

Targeting Investments for Neighborhood Revitalization

497

Targeting Jab1/CSN5 in nasopharyngeal carcinoma

498

Targeting JAK3 with JANEX-1 for prevention of autoimmune type 1 diabetes in NOD mice

499

Targeting Key Genes in the Early Diagnosis and Treatment of Lung Cancer with a Focus on Personalized Medicine: a Review Article

500

Targeting large molecules to mitochondria

501

Targeting large molecules to mitochondria

502

Targeting leukocyte recruitment in the treatment of psoriasis

503

Targeting Lifestyle Change in Patients With Depression

504

Targeting Lifestyle Intervention for Obesity Control Among School Age Children

505

Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth

506

Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table

507

Targeting lipoic acid to mitochondria: Synthesis and characterization of a triphenylphosphonium-conjugated α-lipoyl derivative

508

Targeting liposomes to tumor endothelial cells for neutron capture therapy

509

Targeting Lipoxygenases with Care

510

Targeting Liver Cancer: First Steps toward a miRacle?

511

Targeting long non-coding RNAs as new modulators in anti-EGFR resistance mechanisms

512

Targeting low high-density lipoprotein cholesterol for therapy: lessons from the Veterans Affairs High-density Lipoprotein Intervention Trial

513

Targeting low-arsenic aquifers in Matlab Upazila, Southeastern Bangladesh

514

Targeting Malaria with Polyamines

515

Targeting Mcl-1 for multiple myeloma (MM) therapy: Drug-induced generation of Mcl-1 fragment Mcl-1128–350 triggers MM cell death via c-Jun upregulation

516

Targeting metabolomics analysis of the sunscreen agent 2-ethylhexyl 4-(N,N-dimethylamino)benzoate in human urine by automated on-line solid-phase extraction–liquid chromatography–tandem mass spectrometry with liquid chromatography–time-of-flight/mass spec

517

Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen: Bander NH, Trabulsi EJ, Kostakoglu L, Yao D, Vallabhajosula S, Smith-Jones P, Joyce MA, Milowsky M, Nanus DM

518

Targeting MgrA-Mediated Virulence Regulation in Staphylococcus aureus Original Research Article

519

Targeting micro-sectioning—A technique to study subsurface features in worn specimens

520

Targeting minor histocompatibility antigens in graft versus tumor or graft versus leukemia responses

521

Targeting Mitochondrial and Brain Injury Markers in Acquired Brain Injuries: A Randomized, Double-Blind, Placebo-Controlled Study with Melatonin

522

Targeting mitochondrial biogenesis for preventing and treating insulin resistance in diabetes and obesity: Hope from natural mitochondrial nutrients

523

Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation

524

Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation

525

Targeting Mitochondrial Oxidative Stress in Heart Failure: Throttling the Afterburner

526

Targeting Mitotic Exit Leads to Tumor Regression In Vivo: Modulation by Cdk1, Mastl, and the PP2A/B55α,δ Phosphatase

527

Targeting molecular pathways in endometrial cancer: A focus on the FGFR pathway

528

Targeting Monocyte Recruitment in CNS Autoimmune Disease

529

Targeting moving targets in chaotic dynamical systems

530

Targeting mRNA to regulate iron and oxygen metabolism

531

Targeting Multiple Biofilm Pathways

532

Targeting multiple genetic aberrations in isolated tumor cells by spectral fluorescence in situ hybridization

533

Targeting NAD Biosynthesis in Bacterial Pathogens: Structure-Based Development of Inhibitors of Nicotinate Mononucleotide Adenylyltransferase NadD Original Research Article

534

Targeting Nanostrategies for Imaging of Atherosclerosis

535

Targeting nitric oxide synthase with 99mTc/Re-tricarbonyl complexes containing pendant guanidino or isothiourea moieties

536

Targeting nitric oxide to cancer cells: cytotoxicity studies of glyco-S-nitrosothiols

537

Targeting nitroxides to mitochondria: location, location, location, and …concentration: Highlight Commentary on “Mitochondria superoxide dismutase mimetic inhibits peroxide-induced oxidative damage and apoptosis: Role of mitochondrial superoxide”

538

Targeting nominal income: A closer look

539

Targeting Nonclassical Oncogenes for Therapy in T-ALL

540

Targeting novel and established therapies for non-small cell lung cancer

541

Targeting Occupations in Regional and Community Economic Development

542

Targeting of a Nicotiana plumbaginifolia H+-ATPase to the Plasma Membrane Is Not by Default and Requires Cytosolic Structural Determinants

543

Targeting of Adenovirus Serotype 5 Pseudotyped with Short Fiber from Serotype 41 to c-erbB2-Positive Cells using Bispecific Single-Chain Diabody

544

Targeting of androgen receptor in bone reveals a lack of androgen anabolic action and inhibition of osteogenesis: A model for compartment-specific androgen action in the skeleton

545

Targeting of children in filariasis mass drug administration

546

Targeting of cholera toxin A (ctxA) gene by zinc finger nuclease: pitfalls of using gene editing tools in prokaryotes

547

Targeting of Cytotoxic Luteinizing Hormone-Releasing Hormone Analogs to Breast, Ovarian, Endometrial, and Prostate Cancers

548

Targeting of diethylene triamine pentaacetic acid encapsulated in liposomes to rat liver: an effective strategy to prevent bone deposition and increase urine elimination of plutonium in rats

549

Targeting of epidermal growth factor receptor by cyclopentenone prostaglandin 15-Deoxy-Δ12,14-prostaglandin J2 in human oral squamous carcinoma cells

550

Targeting of Escherichia coli F4 fimbriae to Fcγ receptors enhances the maturation of porcine dendritic cells

551

Targeting of Escherichia coli F4 fimbriae to Fcγ receptors enhances the maturation of porcine dendritic cells

552

Targeting of fluorescent palygorskite polyethyleneimine nanocomposite to cancer cells

553

Targeting of food aid in rural Ethiopia: chronic need or inertia?

554

Targeting of heat-shock protein 32/heme oxygenase-1 in canine mastocytoma cells is associated with reduced growth and induction of apoptosis

555

Targeting of hormone replacement therapy immediately after menopause

556

Targeting of Lin−Sca+ hematopoietic stem cells with bispecific antibodies to injured myocardium

557

Targeting of membrane type1-matrix metalloproteinase (MT1-MMP) using superparamagnetic nanoparticles in human liver cancer cells

558

Targeting of mixed sequence double-stranded DNA using pyrene-functionalized 2-amino(alpha)-L-LNA

559

Targeting of multiple metabolites in neural cells monitored by using protein-based carbon nanotubes

560

Targeting of observations for accidental atmospheric release monitoring

561

Targeting of polyamidoamine–DNA nanoparticles using the Staudinger ligation: Attachment of an RGD motif either before or after complexation Original Research Article

562

Targeting of proteins into and within the chloroplast

563

Targeting of sugar- and charge-modified albumins to fibrotic rat livers: the accessibility of hepatic cells after chronic bile duct ligation

564

Targeting of superoxide dismutase to the liver results in anti-inflammatory effects in rats with fibrotic livers

565

Targeting of the actin cytoskeleton during infection by Salmonella strains

566

Targeting of the highly conserved threonine 302 residue of cytochromes P450 2B family during mechanism-based inactivation by aryl acetylenes

567

Targeting of the Tumor Suppressor GRHL3 by a miR-21-Dependent Proto-Oncogenic Network Results in PTEN Loss and Tumorigenesis

568

Targeting of therapeutic agents to bone to treat metastatic cancer

569

Targeting of vasculature in cancer and other angiogenic diseases

570

Targeting of Venom Phospholipases: The Strongly Anticoagulant Phospholipase A2 from Naja nigricollis Venom Binds to Coagulation Factor Xa to Inhibit the Prothrombinase Complex

571

Targeting oncogene dependence and resistance

572

Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation

573

Targeting Orphan Nuclear Receptors for Treatment of Metabolic Diseases and Autoimmunity Review Article

574

Targeting p53 as a therapeutic strategy in sensitizing TRAIL-induced apoptosis in cancer cells

575

Targeting p53 by PTD-mediated transduction

576

Targeting p73 in cancer

577

Targeting peptide nucleic acid-protein conjugates to structural features within duplex DNA Original Research Article

578

Targeting Pharmacological and Nanotechnology Based Therapeutics for Management of Hirsutism: A Comprehensive State-of-the-Art

579

Targeting phonological representations can help in the early stages of reading in a non–dominant language

580

Targeting Placental Growth Factor/Neuropilin 1 Pathway Inhibits Growth and Spread of Medulloblastoma

581

Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization

582

Targeting Plasmodium host cells: survival within hepatocytes

583

Targeting Platelet Nitric Oxide Resistance With Ramipril: Unraveling Mechanisms of Atherothrombotic Risk Reduction With Angiotensin-Converting Enzyme Inhibitors

584

Targeting platelet/endothelial cell adhesion molecule 1 enhances cisplatin sensitivity of human nasopharyngeal carcinoma cells exposed to ionizing radiation

585

Targeting plug-in hybrid electric vehicle policies to increase social benefits

586

Targeting Plutella xylostella digestive enzymes by applying resistant Brassicaceae host cultivars

587

Targeting podocyte-associated diseases

588

Targeting poly(ADP-ribosyl)ation: a promising approach in cancer therapy

589

Targeting polymer therapeutics to bone

590

Targeting poverty alleviation in priority setting for agricultural research

591

Targeting poverty to improve maternal health in Sokoto State, Nigeria

592

Targeting Priority Populations to Reduce Disparities in Cardiovascular Care: Health Equity for All

593

Targeting programmed cell death pathways with experimental therapeutics: opportunities in high-risk neuroblastoma

594

Targeting prokaryotic choline oxidase into chloroplasts enhance the potential of photosynthetic machinery of plants to withstand oxidative damage

595

Targeting promiscuous signaling pathways in cancer: another Notch in the bedpost

596

Targeting Promising Bread Wheat (Triticum aestivum L.) Lines for Cold Climate Growing Environments Using AMMI and SREG GGE Biplot Analyses

597

Targeting proteins to mitochondria using TAT

598

Targeting P-Selectin During Coronary Interventions: The Elusive Link Between Inflammation and Platelets to Prevent Myocardial Damage

599

Targeting public investments by agro-ecological zone to achieve growth and poverty alleviation goals in rural India

600

Targeting quantitative synthesis for the one-step amination of fatty alcohols and dimethylamine Original Research Article

601

Targeting receptor tyrosine kinase signalling in small cell lung cancer (SCLC): What have we learned so far?

602

Targeting receptor-mediated endocytotic pathways with nanoparticles: Rationale and advances

603

Targeting resource investments to achieve sediment reduction and improved Great Barrier Reef health

604

Targeting Retroviral Zn Finger-DNA Interactions: A Small-Molecule Approach Using the Electrophilic Nature of trans-Platinum-Nucleobase Compounds Original Research Article

605

Targeting RNA with cysteine-constrained peptides

606

Targeting RNA with peptidomimetic oligomers in human cells

607

Targeting rural development interventions: Empirical agent-based modeling in Nigerien villages

608

Targeting senescence pathways to reverse drug resistance in cancer

609

Targeting signal transduction in the discovery of antiproliferative drugs Review Article

610

Targeting sites for conservation: Using a patch-based ranking scheme to assess conservation potential

611

Targeting sites for habitat creation: an investigation into alternative scenarios

612

Targeting Smokers with Low Readiness to Change with Tailored and Nontailored Self-Help Materials,

613

Targeting solid tumors via T cell receptor complementarity-determining region 3δ in an engineered antibody

614

Targeting soluble Aβ peptide with Tramiprosate for the treatment of brain amyloidosis

615

Targeting Specific PDZ Domains of PSD-95: Structural Basis for Enhanced Affinity and Enzymatic Stability of a Cyclic Peptide Original Research Article

616

Targeting Spending for Land Conservation

617

Targeting sphingosine-1-phosphate: A novel avenue for cancer therapeutics

618

Targeting SRC in glioblastoma tumors and brain metastases: Rationale and preclinical studies

619

Targeting Superoxide Dismutase to Renal Proximal Tubule Cells Inhibits Mitochondrial Injury and Renal Dysfunction Induced by Cisplatin

620

Targeting superoxide dismutase to renal proximal tubule cells inhibits nephrotoxicity of cisplatin and increases the survival of cancer-bearing mice

621

Targeting Survival: Integration Site Selection by Retroviruses and LTR-Retrotransposons

622

Targeting survivin in cancer

623

Targeting synthetic analogues of the metallo-sulfur active sites of nickel enzymes capable of important catalysis

624

Targeting Systemically Administered Proteins to Bone by Bisphosphonate Conjugation

625

Targeting Systolic Blood Pressure: The Key to Controlling Combined Systolic/Diastolic Hypertension

626

Targeting Telomerase via Its Key RNA/DNA Heteroduplex

627

Targeting the ‘upper-turn-around’ in atrioventricular nodal reentrant tachycardia

628

Targeting the 90 kDa heat shock protein improves photodynamic therapy

629

Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells

630

Targeting the atherosclerotic process in clinical practice. A new look at established agents

631

Targeting the Bacterial Z-Ring

632

Targeting the ceramide system in cancer

633

Targeting the C-terminal focal adhesion kinase scaffold in pancreatic cancer

634

Targeting the dimerization interface for irreversible inhibition of HIV-1 protease

635

Targeting the DNA minor groove with fused ring dicationic compounds: Comparison of in silico screening and a high-resolution crystal structure

636

Targeting the End: The Structure of the Ku80 C-Terminal Domain

637

Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma

638

Targeting the finite-deformation response of wavy biological tissues with bio-inspired material architectures

639

Targeting the gatekeeper residue in phosphoinositide 3-kinases Original Research Article

640

Targeting the IL-17/IFN-γ axis as a potential new clinical therapy for type 1 diabetes

641

Targeting the impactors: siderophile element signatures of lunar impact melts from Serenitatis

642

Targeting the integration of multi-period utility systems for site scale process integration

643

Targeting the lymphatics using dendritic polymers (dendrimers)

644

Targeting the maximum heat recovery for systems with heat losses and heat gains

645

Targeting the message: A receiver-centered process for public relations writing : William Thompson, White Plains, NY: Longman Publishers, 508 pp., $41.91, paperback 1996

646

Targeting the microenvironment in chronic lymphocytic leukemia offers novel therapeutic options

647

Targeting the molecular chaperone heat shock protein 90 (HSP90): Lessons learned and future directions

648

Targeting the mTOR signaling network in cancer

649

Targeting the neural cell adhesion molecule in cancer

650

Targeting the orexinergic system: Mainly but not only for sleep-wakefulness therapies

651

Targeting the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway: An emerging treatment strategy for squamous cell lung carcinoma

652

Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer

653

Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer

654

Targeting the PI3K/Akt/mTOR Signaling Pathway: Applications of Nanotechnology

655

Targeting the PI3K-Akt pathway in human cancer: Rationale and promise

656

Targeting the poor using community information

657

Targeting the Proangiogenic VEGF-VEGFR Protein-Protein Interface with Drug-like Compounds by In Silico and In Vitro Screening Original Research Article

658

Targeting the Proliferation Inhibition of Chronic Myeloid Leukemia Cells by Bone Marrow Derived-Mesenchymal Stem Cells via ERK Pathway as a Therapeutic Strategy

659

Targeting the Proprotein Convertase Subtilisin/Kexin Type 9 for the Treatment of Dyslipidemia and Atherosclerosis

660

Targeting the RAF–MEK–ERK pathway in cancer therapy

661

Targeting the real exchange rate: theory and evidence

662

Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis

663

Targeting the specificity and function of fibroblast growth factor-1 (acidic FGF) by site-directed mutagenesis

664

Targeting the Sticky Fingers of HIV-1

665

Targeting the tat-binding site of bovine immunodeficiency virus TAR RNA with a shape-selective rhodium complex Original Research Article

666

Targeting the TGFβ signaling network in human neoplasia

667

Targeting the trimolecular complex

668

Targeting the tumor and its microenvironment by a dual-function decoy Met receptor

669

Targeting the tumor necrosis factor-related apoptosis-inducing ligand path in neuroblastoma

670

Targeting the Undruggable Proteome: The Small Molecules of My Dreams

671

Targeting the vulnerable in emergency situations: who is vulnerable?

672

Targeting the X-Linked Inhibitor of Apoptosis Protein through 4-Substituted Azabicyclo[5.3.0]alkane Smac Mimetics. Structure, Activity, and Recognition Principles

673

Targeting the young, the poor, the less educated: thinking beyond traditional media

674

Targeting the α-folate receptor with cyclopenta[g]quinazoline-based inhibitors of thymidylate synthase Original Research Article

675

Targeting thrombin and factor VIIa: design, synthesis, and inhibitory activity of functionally relevant indolizidinones

676

Targeting tissue factor to tumor vasculature

677

Targeting TNF-α suppresses the production of MMP-9 in human salivary gland cells

678

Targeting to sialoadhesin receptor improves antigen presentation to T cells

679

Targeting to sialoadhesin receptor improves antigen presentation to T cells

680

Targeting to sialoadhesin receptor improves antigen presentation to T cells

681

Targeting to sialoadhesin receptor improves antigen presentation to T cells

682

Targeting to sialoadhesin receptor improves antigen presentation to T cells

683

Targeting to sialoadhesin receptor improves antigen presentation to T cells

684

Targeting transforming growth factor-β signaling in liver metastasis of colon cancer

685

Targeting triple negative breast cancer: Is p53 the answer?

686

Targeting truncated APE1 in mitochondria enhances cell survival after oxidative stress

687

Targeting tumor angiogenesis with histone deacetylase inhibitors

688

Targeting Tumor Architecture to Favor Drug Penetration: A New Weapon to Combat Chemoresistance in Pancreatic Cancer?

689

Targeting tumor cell motility to prevent metastasis

690

Targeting tumor microenvironment as a treatment strategy for hepatocellular carcinoma

691

Targeting tumor microenvironment: Crossing tumor interstitial fluid by multifunctional nanomedicines

692

Targeting tumor microenvironment: The key role of immune system

693

Targeting tumors with peptides from natural sources

694

Targeting uPA/uPAR in prostate cancer

695

Targeting Urban Congestion: Equity and Second-Best Issues

696

Targeting urban malnutrition: a multi-city analysis of the spatial distribution of childhood nutritional status

697

Targeting utility customers to improve energy savings from conservation and efficiency programs

698

Targeting versus universalism: An evaluation of indirect effects of the Employment Guarantee Scheme in India

699

Targeting Viral ORF3a Protein: A New Approach to Mitigate COVID-19 Induced Immune Cell Apoptosis and Associated Respiratory Complications

700

Targeting voltage-gated Ca2+ channels

701

Targeting voltage-gated Ca2+ channels

702

Targeting voracious appetite of malaria-infected red-blood cell

703

Targeting Wide-Range Oncogenic Transformation via PU24FCl, a Specific Inhibitor of Tumor Hsp90 Original Research Article

704

Targeting α-Synuclein in Parkinsonʹs Disease Review Article

705

Targeting β2-microglobulin for induction of tumor apoptosis in human hematological malignancies

706

Target–ion-source system for RNB facility at KEK Tanashi Original Research Article

707

Target-making in the Nuclear Physics Department at the Australian National University

708

Target-making in the Nuclear Physics Department at the Australian National University

709

Target-mass corrections and the Bloom-Gilman duality of the nucleon structure function

710

Target-mass dependence of the break-up of halo nuclei

711

Targetome Analysis Revealed Involvement of MiR-126 in Neurotrophin Signaling Pathway: A Possible Role in Prevention of Glioma Development

712

Target-oriented multifunctional organocatalysis for enantioselective synthesis of bicyclo[3.3.1]nona-2,6-dien-9-ones. A formal asymmetric synthesis of huperzine A

713

Target-oriented obstacle analysis by PESTEL modeling of energy efficiency retrofit for existing residential buildings in Chinaʹs northern heating region

714

Target-oriented synthesis: miscellaneous synthetic routes to access 1,4-enediones through the coupling of 1,3-dicarbonyl compounds with multiform substrates

715

Target-plane deposition of diamond-like carbon in pulsed laser ablation of graphite

716

Target-projectile symmetry effects on fast light-particle emissions in heavy ion reactions

717

Target-Pursuing Scheduling and Routing Policies for Multiclass Queueing Networks

718

Targetry for cyclotron production of no-carrier-added cadmium-109 from natAg(p,n)109Cd reaction

719

Targets and ion sources for RIB generation at the Holifield Radioactive Ion Beam Facility

720

Targets and ion sources for RIB generation at the Holifield Radioactive Ion Beam Facility

721

Targets and methods for the detection of processed animal proteins in animal feedstuffs

722

Targets and results of the Brazilian Biodiesel Incentive Program – Has it reached the Promised Land?

723

Targets and Tactics of Play Fighting: Competitive versus Cooperative Styles of Play in Japanese and Tonkean Macaques

724

Targets and target wheel mechanism for APEX

725

Targets and target wheel mechanism for APEX

726

Targetsʹ Awareness of Expectations and Behavioral Confirmation in Ongoing Interactions

727

Targets emitting transition radiation for performing X-ray lithography by the tabletop synchrotron MIRRORCLE-20SX

728

Targets emitting transition radiation for performing X-ray lithography by the tabletop synchrotron MIRRORCLE-20SX

729

Targets for Anti-HIV1- Agents as Personalized HIV Therapy: A Review Study

730

Targets for bulk hydrogen analysis using thermal neutrons

731

Targets for bulk hydrogen analysis using thermal neutrons

732

Targets for cancer therapy in childhood sarcomas

733

Targets for indole-3-carbinol in cancer prevention

734

Targets for laser-driven opacity measurements

735

Targets for mitigation of Greenhouse gases : Implications from a long-term perspective

736

Targets for S3 at SPIRAL2

737

Targets for S3 at SPIRAL2

738

Targets for the APEX experiment at ATLAS

739

Targets for the electron–positron pair spectrometer HADES

740

Targets for the electron–positron pair spectrometer HADES

741

Targets now set by G8 countries to reduce “diseases of poverty”

742

Targets of discrimination: Effects of race on responses to weapons holders

743

Targets of Nitric Oxide in a Mouse Model of Liver Inflammation by Corynebacterium parvum

744

Targets of opportunity in two landscapes of financial globalization

745

Targets of RNA-directed DNA methylation

746

Targets of uranium, plutonium, and curium for heavy-element research

747

Targets of uranium, plutonium, and curium for heavy-element research

748

Targets on superhydrophobic surfaces for laser ablation ion sources

749

Targets on superhydrophobic surfaces for laser ablation ion sources

750

Targets used in the production of radioactive ion beams at the HRIBF

751

Targets used in the production of radioactive ion beams at the HRIBF

752

Targets, drivers and metrics in software process improvement: Results of a survey in a multinational organization

753

Target-shaped possibilistic clustering applied to local-model identification

754

Target-site insensitivity to some acaricides in a field population of Tetranychus urticae Koch (Acari: Tetranychidae) from Egypt

755

Target-site Preferences of Sleeping Beauty Transposons Original Research Article

756

Target-space duality in heterotic and type I effective Lagrangians Original Research Article

757

Target-specific control of lymphoid-specific protein tyrosine phosphatase (Lyp) activity Original Research Article

758

Target-specific delivery of peptide-based probes for PET imaging

759

Target-specific rib biopsy using the gamma probe

760

Target-specific Tc(CO)3-complexes for in vivo imaging

761

Target-superspace in 2d dilatonic supergravity

762

Target-synchronization of the distributed wireless sensor networks under the same sleeping–awaking method

763

Targetting voltage-gated calcium channels in cardiovascular therapy

764

TARGISOL: An ISOL-database on the web

765

TARGUM AND TRANSLATION: A NEW APPROACH TO A CLASSIC PROBLEM

766

Ta–Rh binary alloys as a potential diffusion barrier between Cu and Si: Stability and failure mechanism of the Ta–Rh amorphous structures Original Research Article

767

Tariff and quota equivalence in the presence of asymmetric information

768

Tariff and tax reform: Dynamic implications

769

Tariff bindings and bilateral cooperation on export cartels

770

Tariff concessions in production sourcing

771

Tariff design with varying degrees of commitment

772

Tariff endogeneity: Evidence from 19th century Europe

773

Tariff escalation and invasive species damages

774

Tariff games: Cooperation with random variation in political regimes

775

Tariff jumping DFI and export substitution: Japanese electronics firms in Europe

776

Tariff jumping foreign investment and capital taxation

777

Tariff Pass-through and Firm’s Productivity: A Case Study of Iran

778

Tariff policy for a monopolist in a signaling game

779

Tariff rate quotas: structural and stability impacts in growing markets

780

Tariff Reduction, Tax Replacement, and Implications for Income Distribution in China,

781

Tariff revenue competition in a free trade area

782

Tariff structure of Japanese electric power companies: An empirical analysis using DEA

783

Tariff structures and access substitution of mobile cellular for fixed line in South Africa

784

Tariff-based incentives for improving coal-power-plant efficiencies in India

785

Tariffication and the Canadian Chicken Industry in the Uruguay Round Agreement

786

Tariff-induced capital inflow and welfare in the presence of unemployment and informal sector

787

Tariffing in the new IP/ATM environment

788

Tariff-jumping antidumping duties

789

Tariff-quality equilibrium and its implications for telecommunications regulation

790

Tariff-Rate Quota Liberalization: The Case of World Price Uncertainty and Supply Management

791

Tariffs and exchange rate dynamics redux

792

Tariffs and Schumpeterian growth

793

Tariffs and subsidies in Zimbabweʹs reforming electricity industry: steering a utility through turbulent times

794

Tariffs and the Byrd amendment

795

Tariffs and the most favored nation clause

796

Tariffs in monopolistic competition models with leisure-consumption trade-off

797

Tariffs, licensing and market structure

798

Tariffs, quality reversals and exit in vertically differentiated industries

799

Tariffs, quotas and terms-of-trade: The case of New Zealand

800

Târih-i Selânikî As A Social History Guide

801

Tarihin İçinden Geçerek Tarihi İzlemek, İrdelemek: Uluslararası Bilim Düşünce ve Sanatta Cizre Sempozyumu

802

Tarihsel Bağlam ve İsrâiliyyâtın Rivayetlerin Oluşumundaki Etkisi –Nüzulü İsa ile Alâkalı Bir Rivayet Bağlamında–

803

Tarihten Notlar: Abbas Vesim Efendi (öl.1760)

804

Tarihten Notlar: Ord. Prof. Dr. Cemil Topuzlu (1866-1958)

805

TARIK BUĞRA’S LANGUAGE, ART AND LITERATURE OPINIONS FROM DÜŞMAN KAZANMAK SANATI

806

Tarmo: A Framework for Parallelized Bounded Model Checking

807

Tarnish protection of silver by octadecanethiol self-assembled monolayers prepared in aqueous micellar solution

808

Tarnish protection of silver jewels by plasmapolymer coatings

809

Tarnishing resistance of silver–palladium thin films

810

TARP: A traffic-aware restructuring protocol for Bluetooth radio networks

811

TARP: Ticket-based address resolution protocol

812

Tarsal morphology and attachment ability of the codling moth Cydia pomonella L. (Lepidoptera, Tortricidae) to smooth surfaces

813

Tarsal movements in flies during leg attachment and detachment on a smooth substrate

814

Tarsal Suspension Canthoplasty,

815

Tarsal taste neurons of Helicoverpa assulta (Guenée) respond to sugars and amino acids, suggesting a role in feeding and oviposition

816

Tarsal tunnel syndrome after total ankle replacement—a report of 3 cases

817

Tarsal tunnel syndrome caused by talocalcaneal coalition

818

Tarsal tunnel syndrome in patients with rheumatoid arthritis, electrophysiological and ultrasound study

819

tar-shaped oligo(p-phenylene)-functionalized truxenes as blue-light-emitting materials: synthesis and the structure–property relationship

820

Tarsier and ICMS: two approaches to framework development Original Research Article

821

Tarsier: a practical software framework for model development, testing and deployment

822

Tarski, truth and natural languages Original Research Article

823

Tarskian Set Constraints

824

Tarskiʹs conception of logic Original Research Article

825

Tarskiʹs definition and truth-makers Original Research Article

826

Tarskiʹs theory of definability: common themes in descriptive set theory, recursive function theory, classical pure logic, and finite-universe logic Original Research Article

827

Tart cherry anthocyanins inhibit tumor development in ApcMin mice and reduce proliferation of human colon cancer cells

828

Tartaglia’s ragioni: A maestro d’abaco’s mixed approach to the bombardier’s problem

829

Tartan Colour to sell for MD-Both & Wolstenholme

830

Tartarate precursors to CoxZn1−xGa2O4 spinel oxides

831

Tartaric acid assisted synthesis of Li2FeSiO4/C: Effect of carbon content on the electrochemical performance of Li2FeSiO4/C for lithium ion batteries

832

Tartaric acid production by ion exchange resin-filling electrometathesis and its process economics

833

Tartaric acid-assisted sol–gel synthesis of LiNi0.5Co0.5−xTixO2 (0 ⩽ x ⩽ 0.5) as cathode materials for lithium-ion batteries

834

Tartaric acid-assisted sol–gel synthesis of LiNi0.8Co0.2O2 and its electrochemical properties as a cathode material for lithium batteries

835

Tartaric acid–Ni supported catalysts obtained from hydrotalcite-like compounds: Effects of catalyst preparation variables on enantioselectivity Original Research Article

836

Tartary buckwheat improves cognition and memory function in an in vivo amyloid-β-induced Alzheimer model

837

Tartradiamide formation by thermolysis of tartaric acid with alkylamines

838

Tartrate dehydrogenase reductive decarboxylation: stereochemical generation of diastereotopically deuterated hydroxymethylenes

839

Tartrate Dehydrogenase, a New Member of the Family of Metal-Dependent Decarboxylating R-Hydroxyacid Dehydrogenases

840

Tartrate Dehydrogenase-Oxalate Complexes: Formation of a Stable Analog of a Reaction Intermediate Complex

841

Tartrate resistant acid phosphatase (TRACP 5b) as a resorption marker in patients with secondary hyperparathyroidism treated with cinacalcet

842

Tartrate-resistant acid phosphatase 5a and 5b contain distinct sugar moieties

843

Tartrazine Removal from Aqueous Solution by HDTMA-Br-Modified Colombian Bentonite

844

Tartuferiʹs retina

845

Tarwinia australis (Siphonaptera: Tarwiniidae) from the Lower Cretaceous Koonwarra fossil bed: Morphological revision and analysis of its evolutionary relationship

846

Tarzan as a cultural prism: Ideological Associations in Edgar Rice Burroughs’s Tarzan of the Apes

847

TASA: A New Task Scheduling Algorithm in Cloud Computing

848

Tasahul imam al-tirmidhi terhadap hukum hadith : Analisis pendapat ulama

849

Tasawuf in Different Derivations

850

TASC: Two-attribute-set clustering through decision tree construction

851

TaSe, a Taylor series-based fuzzy system model that combines interpretability and accuracy

852

Taser Research in Pigs Not Helpful

853

TASG: An Augmented Classification Method for Impersonal HAR

854

tashkent Uzbek health care—no longer back in the USSR

855

Ta–Si contacts to n-SiC for high temperatures devices

856

TASISpec—A highly efficient multi-coincidence spectrometer for nuclear structure investigations of the heaviest nuclei

857

TASISpec—A highly efficient multi-coincidence spectrometer for nuclear structure investigations of the heaviest nuclei

858

Task analysis for computer-aided design (CAD) at a keystroke level

859

Task analysis interview based on task ontology

860

Task analysis of human-in-the-loop tele-operated maintenance: What can be learned from JET?

861

Task analysis training of case managers to assist seriously mentally ill patients find roommates and housing

862

Task analysis, calculation and approximation: The work of Stuart K. Card, 2007 Bower Laureate in Computer & Cognitive Science for Human-Centered Computing

863

Task and socioemotional behaviors of physicians: a test of reciprocity and social interaction theories in analogue physician–patient encounters

864

Task and technology fit: a comparison of two technologies for synchronous and asynchronous group communication

865

Task assignment and transaction clustering heuristics for distributed systems

866

Task assignment in a heterogeneous server farm with switching delays and general energy-aware cost structure

867

Task automata: Schedulability, decidability and undecidability

868

Task aversiveness and procrastination: a multi-dimensional approach to task aversiveness across stages of personal projects

869

Task Classification Based Energy-Aware Consolidation in Clouds

870

Task cluster scheduling in a grid system

871

Task completion competency and project management performance: The influence of control and user contribution

872

Task complexity affects information seeking and use

873

Task Complexity and Grammatical Development in English as a Second Language

874

Task complexity and linguistic and discourse features of narrative writing performance

875

Task Complexity and the Speed and Efficiency of Elemental Information Processing: Another Look at the Nature of Intellectual Giftedness

876

Task Complexity Manipulation and Accuracy in Writing Performance

877

Task Complexity Manipulation and EFL learners’ interactions in the process of collaborative pre-planning

878

Task Complexity Manipulation and EFL learners’ interactions in the process of collaborative pre-planning

879

TASK COMPLEXITY, FOCUS ON FORM, AND SECOND LANGUAGE DEVELOPMENT

880

Task complexity, problem structure and information actions: Integrating studies on information seeking and retrieval

881

Task concentration training versus applied relaxation, in combination with cognitive therapy, for social phobia patients with fear of blushing, trembling, and sweating

882

Task Condition and EFL Learners’ Individual Differences: The Mediation of Tolerance of Ambiguity and Self-efficacy

883

Task Condition and L2 oral Performance: Investigating the Combined Effects of Online Planning and Immediacy

884

Task constraints and visual feature binding

885

Task coordination and aging: explorations of executive control processes in the task switching paradigm

886

Task decomposition and modular single-hidden-layer perceptron classifiers for multi-class learning problems

887

Task decomposition on abstract states, for planning under nondeterminism Original Research Article

888

Task demand effects on postural control in older adults

889

Task demands and human capabilities in door use

890

Task demands and knowledge influence how children learn to read words

891

Task dependence of Ia presynaptic inhibition in human wrist extensor muscles: a single motor unit study

892

Task dependency in back muscle fatigue – Correlations between two test methods

893

Task dependent cross-modal processing in early sensory cortices

894

Task Design Characteristics and EFL Learners’ Complexity, Accuracy and Fluency during Uncontrolled Pair Interactions: A Naturalistic Perspective

895

Task design, psycho-social work climate and upper extremity pain disorders - effects of an organisational redesign on manual repetitive assembly jobs

896

Task Development for an Online English Technical Vocabulary Self-Learning System for Engineering Students

897

Task Difficulty and Its Components: Are They Alike or Different across Different Macro-genres?

898

Task difficulty in a simultaneous face matching task modulates activity in face fusiform area

899

Task difficulty in speaking tests

900

Task difficulty, incentive effects, and the selection of high-variance strategies: an experimental examination of tournament behavior

901

Task difficulty, task variability and satisfaction with management support systems

902

Task difficulty, task variability and satisfaction with management support systems

903

Task Effectiveness Predictors: Technique Feature Analysis versus Involvement Load Hypothesis

904

Task effects in masked cross-script translation and phonological priming

905

Task effects reveal cognitive flexibility responding to frequency and predictability: Evidence from eye movements in reading and proofreading

906

Task effects, performance levels, features, configurations, and holistic face processing: A reply to Rossion

907

Task experience and validity in perceptual mapping A comparison of two consumer-adaptive techniques

908

Task force #1—identification of coronary heart disease risk: is there a detection gap?

909

Task Force #1—magnitude of the prevention problem: opportunities and challenges

910

Task Force #2—the cost of prevention: can we afford it? Can we afford not to do it?

911

Task force #2—what is the pathologic basis for new atherosclerosis imaging techniques?

912

Task Force #3—getting results: who, where, and how?

913

Task force #3—what is the spectrum of current and emerging techniques for the noninvasive measurement of atherosclerosis?

914

Task Force #4—adherence issues and behavior changes: achieving a long-term solution

915

Task force #4—how do we select patients for atherosclerosis imaging?

916

Task force #5—is atherosclerosis imaging cost effective?

917

Task Force #5—the role of cardiovascular specialists as leaders in prevention: from training to champion

918

Task force 1. Pathogenesis of coronary disease: The biologic role of risk factors

919

Task Force 1: General Experiences and Training Review Article

920

Task Force 1: Preparticipation screening and diagnosis of cardiovascular disease in athletes Review Article

921

Task Force 1: The ACCF and AHA codes of conduct in human subjects research Review Article

922

Task Force 1: the changing profile of congenital heart disease in adult life

923

Task force 1: Training in clinical cardiology

924

Task Force 1: Training in Clinical Cardiology Review Article

925

Task Force 10: Automated external defibrillators Review Article

926

Task force 10: Training in preventive cardiovascular medicine

927

Task Force 10: Training in Preventive Cardiovascular Medicine Review Article

928

Task Force 11: Commotio cordis Review Article

929

Task Force 11: Training in Vascular Medicine and Peripheral Vascular Catheter-Based Interventions: Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society for Vascular Medicine Review Article

930

Task Force 12: Legal aspects of the 36th Bethesda Conference recommendations Review Article

931

Task Force 12: Training in Advanced Cardiovascular Imaging (Cardiovascular Magnetic Resonance [CMR]): Endorsed by the Society for Cardiovascular Magnetic Resonance Review Article

932

Task Force 12: Training in Advanced Cardiovascular Imaging (Cardiovascular Magnetic Resonance [CMR]): Endorsed by the Society for Cardiovascular Magnetic Resonance Review Article

933

Task Force 12: Training in Advanced Cardiovascular Imaging (Computed Tomography): Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Atherosclerosis Imaging and Prevention, and Soci

934

Task Force 13: Training in Advanced Cardiovascular Imaging (Computed Tomography): Endorsed by the American Society of Nuclear Cardiology, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, and Soci

935

Task force 2. Clinical epidemiology: The conceptual basis for interpreting risk factors

936

Task Force 2: Congenital heart disease Review Article

937

Task force 2: Investigator participation in clinical research Review Article

938

Task Force 2: Pediatric Training Guidelines for Noninvasive Cardiac Imaging: Endorsed by the American Society of Echocardiography and the Society of Pediatric Echocardiography Review Article

939

Task Force 2: special health care needs of adults with congenital heart disease

940

Task force 2: Training in electrocardiography, ambulatory electrocardiography and exercise testing

941

Task Force 2: Training in Electrocardiography, Ambulatory Electrocardiography, and Exercise Testing Review Article

942

Task force 3. Spectrum of risk factors for coronary heart disease

943

Task force 3: Disclosure of relationships with commercial interests: Policy for educational activities and publications Review Article

944

Task Force 3: Training Guidelines for Pediatric Cardiac Catheterization and Interventional Cardiology: Endorsed by the Society for Cardiovascular Angiography and Interventions Review Article

945

Task force 3: Training in cardiac catheterization and interventional cardiology

946

Task Force 3: Training in Diagnostic and Interventional Cardiac Catheterization: Endorsed by the Society for Cardiovascular Angiography and Interventions Review Article

947

Task Force 3: Valvular heart disease Review Article

948

Task Force 3: workforce description and educational requirements for the care of adults with congenital heart disease

949

Task force 4. Efficacy of risk factor management

950

Task force 4: Appropriate clinical care and issues of “self-referral” Review Article

951

Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome Review Article

952

Task Force 4: organization of delivery systems for adults with congenital heart disease

953

Task Force 4: Recommendations for Training Guidelines in Pediatric Cardiac Electrophysiology: Endorsed by the Heart Rhythm Society Review Article

954

Task force 4: Training in echocardiography

955

Task Force 4: Training in Echocardiography: Endorsed by the American Society of Echocardiography Review Article

956

Task force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management

957

Task Force 5: adults with congenital heart disease: access to care

958

Task force 5: Expert testimony and opinions Review Article

959

Task Force 5: Requirements for Pediatric Cardiac Critical Care Review Article

960

Task Force 5: Systemic hypertension Review Article

961

Task force 5: Training in nuclear cardiology

962

Task Force 5: Training in Nuclear Cardiology: Endorsed by the American Society of Nuclear Cardiology Review Article

963

Task Force 5: Training in Nuclear Cardiology: Endorsed by the American Society of Nuclear Cardiology Review Article

964

Task force 6. Cost effectiveness of assessment and management of risk factors

965

Task force 6: Code of conduct for staff and volunteer leadership Review Article

966

Task Force 6: Coronary artery disease Review Article

967

Task force 6: Training in specialized electrophysiology, cardiac pacing and arrhythmi management

968

Task Force 6: Training in Specialized Electrophysiology, Cardiac Pacing, and Arrhythmia Management: Endorsed by the Heart Rhythm Society Review Article

969

Task Force 6: Training in Specialized Electrophysiology, Cardiac Pacing, and Arrhythmia Management: Endorsed by the Heart Rhythm Society Review Article

970

Task Force 6: Training in Transition of Adolescent Care and Care of the Adult With Congenital Heart Disease Review Article

971

Task force 7. Evaluation and management of risk factors for the individual patient (case management)

972

Task Force 7: Arrhythmias Review Article

973

Task Force 7: Training Guidelines for Research in Pediatric Cardiology Review Article

974

Task force 7: Training in cardiovascular research

975

Task Force 7: Training in Cardiovascular Research Review Article

976

Task force 8. Organization of preventive cardiology service

977

Task Force 8: Classification of sports Review Article

978

Task force 8: Training in heart failure and transplantation

979

Task Force 8: Training in Heart Failure: Endorsed by the Heart Failure Society of America Review Article

980

Task Force 9: Drugs and performance-enhancing substances Review Article

981

Task force 9: Training in the care of adult patients with congenital heart disease

982

Task Force 9: Training in the Care of Adult Patients With Congenital Heart Disease Review Article

983

Task Force I: Direct Cardiovascular Implications of Emerging Infectious Diseases and Biological Terrorism Threats Review Article

984

Task Force II: Indirect and Secondary Cardiovascular Effects of Biological Terrorism Agents and Diseases Review Article

985

Task Force III: Prevention and Control of Cardiovascular Complications of Emerging Infectious Diseases and Potential Biological Terrorism Agents and Diseases Review Article

986

Task Force IV: Cardiovascular Effects of Emerging Infectious Diseases and Biological Terrorism Threats: Basic, Clinical, and Population Science Research and Training Needs Review Article

987

Task Force of the European Federation of Medical Informatics Journals: Background, Rationale and Purpose

988

TASK FORCE ON ALZHEIMER’S DISEASE TRIAL METHODOLOGY: RECRUITMENT AND RETENTION, DATA MANAGEMENT AND ANALYSIS. THE USE OF IMAGING IN RECRUITMENT: MAINTENANCE AND METHODOLOGICAL ISSUES IN ALZHEIMERʹS TRIALS

989

Task gender orientation perceptions by novice designers: implications for engineering design research, teaching and practice

990

Task goals and change in dynamical degrees of freedom with motor learning.

991

Task Implementation and EFL Learners’ Attention to Form: Examining the Effects of Pre-Task Planning and Post-Task transcription

992

Task Influences on Students’ Collaboration in Mathematics Teaching

993

Task instructions and implicit theory of mind

994

Task instructions modulate neural responses to fearful facial expressions

995

Task Integrated Objective Structured Clinical Examination (TIOSCE): A modified version of OSCE

996

Task Interest and Actual Performance: The Moderating Effects of Assigned and Adopted Purpose Goals

997

Task interference in time-based, event-based, and dual intention prospective memory conditions

998

Task interruptability and duration as measures of visual distraction

999

Task management support in information seeking: a case for search histories

1000

Task mapping on supercomputers with cellular networks Original Research Article

بازگشت